Specialists in biomolecules
One of our priorities is to improve the quality of life of the over 200 million patients in the world who suffer from osteoarthritis, joint lesions and muscular-skeletal disorders. Therefore, as well as Heparin, at Bioibérica we produce other biomolecules like Chondroitin Sulfate, Glucosamine, Hyaluronic Acid or Collagen, indicated for the treatment of these illnesses.
This specialization in joint health has contributed to being endorsed by numerous published clinical trials, ongoing research projects, the recognition of different scientific and medical societies, and the publication of specialized publications. Below you can consult our product portfolio:
Bioiberica researches, develops, manufactures and markets the main molecules for treating osteoarthiritis: chondroitin sulphate, glucosamine and hyaluronic acid.
Chondroitin sulfate, glucosamine and hyaluronic acid are drugs that act directly on the joint structures affected by osteoarthritis.
Innovative range of branded ingredients, within the nutraceutics line, for the development of develop nutritional complements aimed at improving joint health.
Specific products for nourishing the affected joint tissue, such as tendons, ligaments, the synovial membrane and the subchondral bone.
Here at Bioibérica we are also strongly committed to research into personalized medicine and we have the first genetic test for predicting the progression of osteoarthritis of the knee.